This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
99.7% Sustained Virologic Response Rate in 369 HCV Genotype 1b‐Infected Patients Treated With Label‐Recommended Regimen of Ombitasvir/Paritaprevir/r and Dasabuvir With or Without Ribavirin: 2016. (October 2015)
Record Type:
Journal Article
Title:
99.7% Sustained Virologic Response Rate in 369 HCV Genotype 1b‐Infected Patients Treated With Label‐Recommended Regimen of Ombitasvir/Paritaprevir/r and Dasabuvir With or Without Ribavirin: 2016. (October 2015)
Main Title:
99.7% Sustained Virologic Response Rate in 369 HCV Genotype 1b‐Infected Patients Treated With Label‐Recommended Regimen of Ombitasvir/Paritaprevir/r and Dasabuvir With or Without Ribavirin